AFG32_HUMAN - dbPTM
AFG32_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID AFG32_HUMAN
UniProt AC Q9Y4W6
Protein Name AFG3-like protein 2
Gene Name AFG3L2
Organism Homo sapiens (Human).
Sequence Length 797
Subcellular Localization Mitochondrion . Mitochondrion inner membrane
Multi-pass membrane protein .
Protein Description ATP-dependent protease which is essential for axonal and neuron development. In neurons, mediates degradation of SMDT1/EMRE before its assembly with the uniporter complex, limiting the availability of SMDT1/EMRE for MCU assembly and promoting efficient assembly of gatekeeper subunits with MCU. [PubMed: 27642048 Required for the maturation of paraplegin (SPG7) after its cleavage by mitochondrial-processing peptidase (MPP), converting it into a proteolytically active mature form (By similarity]
Protein Sequence MAHRCLRLWGRGGCWPRGLQQLLVPGGVGPGEQPCLRTLYRFVTTQARASRNSLLTDIIAAYQRFCSRPPKGFEKYFPNGKNGKKASEPKEVMGEKKESKPAATTRSSGGGGGGGGKRGGKKDDSHWWSRFQKGDIPWDDKDFRMFFLWTALFWGGVMFYLLLKRSGREITWKDFVNNYLSKGVVDRLEVVNKRFVRVTFTPGKTPVDGQYVWFNIGSVDTFERNLETLQQELGIEGENRVPVVYIAESDGSFLLSMLPTVLIIAFLLYTIRRGPAGIGRTGRGMGGLFSVGETTAKVLKDEIDVKFKDVAGCEEAKLEIMEFVNFLKNPKQYQDLGAKIPKGAILTGPPGTGKTLLAKATAGEANVPFITVSGSEFLEMFVGVGPARVRDLFALARKNAPCILFIDEIDAVGRKRGRGNFGGQSEQENTLNQLLVEMDGFNTTTNVVILAGTNRPDILDPALLRPGRFDRQIFIGPPDIKGRASIFKVHLRPLKLDSTLEKDKLARKLASLTPGFSGADVANVCNEAALIAARHLSDSINQKHFEQAIERVIGGLEKKTQVLQPEEKKTVAYHEAGHAVAGWYLEHADPLLKVSIIPRGKGLGYAQYLPKEQYLYTKEQLLDRMCMTLGGRVSEEIFFGRITTGAQDDLRKVTQSAYAQIVQFGMNEKVGQISFDLPRQGDMVLEKPYSEATARLIDDEVRILINDAYKRTVALLTEKKADVEKVALLLLEKEVLDKNDMVELLGPRPFAEKSTYEEFVEGTGSLDEDTSLPEGLKDWNKEREKEKEEPPGEKVAN
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
14S-palmitoylationRLWGRGGCWPRGLQQ
HHHCCCCCCCCCHHH
5.1429575903
99PhosphorylationVMGEKKESKPAATTR
HCCCCCCCCCCCCCC
53.4729083192
100AcetylationMGEKKESKPAATTRS
CCCCCCCCCCCCCCC
39.5020167786
104PhosphorylationKESKPAATTRSSGGG
CCCCCCCCCCCCCCC
25.5029083192
105PhosphorylationESKPAATTRSSGGGG
CCCCCCCCCCCCCCC
24.6729083192
107PhosphorylationKPAATTRSSGGGGGG
CCCCCCCCCCCCCCC
31.1029083192
108PhosphorylationPAATTRSSGGGGGGG
CCCCCCCCCCCCCCC
37.8629083192
117SuccinylationGGGGGGGKRGGKKDD
CCCCCCCCCCCCCCC
51.66-
117SuccinylationGGGGGGGKRGGKKDD
CCCCCCCCCCCCCCC
51.66-
121MalonylationGGGKRGGKKDDSHWW
CCCCCCCCCCCCCCH
56.7230639696
122MalonylationGGKRGGKKDDSHWWS
CCCCCCCCCCCCCHH
70.7826320211
150PhosphorylationFRMFFLWTALFWGGV
HHHHHHHHHHHHHHH
18.6846160193
160PhosphorylationFWGGVMFYLLLKRSG
HHHHHHHHHHHHHCC
4.3746160211
173UbiquitinationSGREITWKDFVNNYL
CCCCCCHHHHHHHHH
32.4121890473
179PhosphorylationWKDFVNNYLSKGVVD
HHHHHHHHHCCCCHH
13.7222817900
182UbiquitinationFVNNYLSKGVVDRLE
HHHHHHCCCCHHHHH
53.8021890473
193UbiquitinationDRLEVVNKRFVRVTF
HHHHHCCCCEEEEEE
35.29-
193AcetylationDRLEVVNKRFVRVTF
HHHHHCCCCEEEEEE
35.2930585747
1932-HydroxyisobutyrylationDRLEVVNKRFVRVTF
HHHHHCCCCEEEEEE
35.29-
218PhosphorylationYVWFNIGSVDTFERN
EEEEEECCHHHHHHH
17.0246160187
221PhosphorylationFNIGSVDTFERNLET
EEECCHHHHHHHHHH
25.8246160199
270PhosphorylationIIAFLLYTIRRGPAG
HHHHHHHHHHHCCCC
14.1524719451
285SulfoxidationIGRTGRGMGGLFSVG
CCCCCCCCCCCEECC
3.5621406390
290PhosphorylationRGMGGLFSVGETTAK
CCCCCCEECCHHHHH
33.9722210691
300AcetylationETTAKVLKDEIDVKF
HHHHHHHHHHCCCCC
57.1926051181
300UbiquitinationETTAKVLKDEIDVKF
HHHHHHHHHHCCCCC
57.19-
306AcetylationLKDEIDVKFKDVAGC
HHHHCCCCCCCCCCC
42.8419608861
308SuccinylationDEIDVKFKDVAGCEE
HHCCCCCCCCCCCHH
45.6427452117
308AcetylationDEIDVKFKDVAGCEE
HHCCCCCCCCCCCHH
45.6426051181
308MalonylationDEIDVKFKDVAGCEE
HHCCCCCCCCCCCHH
45.6430639696
331SuccinylationVNFLKNPKQYQDLGA
HHHHHCHHHHHCCCC
71.6623954790
331UbiquitinationVNFLKNPKQYQDLGA
HHHHHCHHHHHCCCC
71.66-
3312-HydroxyisobutyrylationVNFLKNPKQYQDLGA
HHHHHCHHHHHCCCC
71.66-
331MalonylationVNFLKNPKQYQDLGA
HHHHHCHHHHHCCCC
71.6626320211
331AcetylationVNFLKNPKQYQDLGA
HHHHHCHHHHHCCCC
71.6625953088
342UbiquitinationDLGAKIPKGAILTGP
CCCCCCCCCCEEECC
65.5321890473
352PhosphorylationILTGPPGTGKTLLAK
EEECCCCCCHHHHHH
41.08110761159
354UbiquitinationTGPPGTGKTLLAKAT
ECCCCCCHHHHHHHH
35.52-
402GlutathionylationLARKNAPCILFIDEI
HHHCCCCEEEEEEEC
3.8122555962
425PhosphorylationRGNFGGQSEQENTLN
CCCCCCCCHHHHHHH
44.5124043423
430PhosphorylationGQSEQENTLNQLLVE
CCCHHHHHHHHHHHH
26.7424043423
443PhosphorylationVEMDGFNTTTNVVIL
HHCCCCCCCCCEEEE
32.5124043423
444PhosphorylationEMDGFNTTTNVVILA
HCCCCCCCCCEEEEE
19.9224043423
445PhosphorylationMDGFNTTTNVVILAG
CCCCCCCCCEEEEEC
24.7924043423
453PhosphorylationNVVILAGTNRPDILD
CEEEEECCCCCCCCC
23.5824043423
481MalonylationFIGPPDIKGRASIFK
EECCCCCCCCCEEEE
50.1226320211
481UbiquitinationFIGPPDIKGRASIFK
EECCCCCCCCCEEEE
50.1221890473
485PhosphorylationPDIKGRASIFKVHLR
CCCCCCCEEEEEEEC
27.4824719451
488MalonylationKGRASIFKVHLRPLK
CCCCEEEEEEECCCC
27.3726320211
498PhosphorylationLRPLKLDSTLEKDKL
ECCCCCCCHHHHHHH
45.3824670416
502SuccinylationKLDSTLEKDKLARKL
CCCCHHHHHHHHHHH
64.3727452117
502AcetylationKLDSTLEKDKLARKL
CCCCHHHHHHHHHHH
64.3726051181
502MalonylationKLDSTLEKDKLARKL
CCCCHHHHHHHHHHH
64.3726320211
504MalonylationDSTLEKDKLARKLAS
CCHHHHHHHHHHHHH
55.9326320211
508UbiquitinationEKDKLARKLASLTPG
HHHHHHHHHHHCCCC
42.68-
543MalonylationLSDSINQKHFEQAIE
HCHHHCHHHHHHHHH
45.8626320211
543AcetylationLSDSINQKHFEQAIE
HCHHHCHHHHHHHHH
45.8623954790
543UbiquitinationLSDSINQKHFEQAIE
HCHHHCHHHHHHHHH
45.8621890473
558MalonylationRVIGGLEKKTQVLQP
HHHHHHHHHCEECCH
67.1926320211
558UbiquitinationRVIGGLEKKTQVLQP
HHHHHHHHHCEECCH
67.19-
5582-HydroxyisobutyrylationRVIGGLEKKTQVLQP
HHHHHHHHHCEECCH
67.19-
5592-HydroxyisobutyrylationVIGGLEKKTQVLQPE
HHHHHHHHCEECCHH
34.51-
559MalonylationVIGGLEKKTQVLQPE
HHHHHHHHCEECCHH
34.5126320211
559SuccinylationVIGGLEKKTQVLQPE
HHHHHHHHCEECCHH
34.5127452117
560PhosphorylationIGGLEKKTQVLQPEE
HHHHHHHCEECCHHH
34.6746160205
568AcetylationQVLQPEEKKTVAYHE
EECCHHHHCCEEEHH
52.6726051181
611AcetylationGYAQYLPKEQYLYTK
CCHHCCCHHHHCCCH
55.6526051181
611UbiquitinationGYAQYLPKEQYLYTK
CCHHCCCHHHHCCCH
55.6521890473
614PhosphorylationQYLPKEQYLYTKEQL
HCCCHHHHCCCHHHH
11.63110761165
618UbiquitinationKEQYLYTKEQLLDRM
HHHHCCCHHHHHHHH
29.88-
6182-HydroxyisobutyrylationKEQYLYTKEQLLDRM
HHHHCCCHHHHHHHH
29.88-
624MethylationTKEQLLDRMCMTLGG
CHHHHHHHHHHHHCC
21.85-
634PhosphorylationMTLGGRVSEEIFFGR
HHHCCCCCCHHCCCC
28.3120068231
689PhosphorylationDMVLEKPYSEATARL
CEEEECCCCHHHHHH
30.1520068231
690PhosphorylationMVLEKPYSEATARLI
EEEECCCCHHHHHHC
29.3120068231
693PhosphorylationEKPYSEATARLIDDE
ECCCCHHHHHHCCHH
14.3020068231
7102-HydroxyisobutyrylationILINDAYKRTVALLT
HHHCHHHHHHHHHHH
43.23-
710AcetylationILINDAYKRTVALLT
HHHCHHHHHHHHHHH
43.2325953088
710SuccinylationILINDAYKRTVALLT
HHHCHHHHHHHHHHH
43.2327452117
712PhosphorylationINDAYKRTVALLTEK
HCHHHHHHHHHHHCC
13.1320068231
7192-HydroxyisobutyrylationTVALLTEKKADVEKV
HHHHHHCCCCCHHHH
48.29-
7252-HydroxyisobutyrylationEKKADVEKVALLLLE
CCCCCHHHHHHHHHH
32.43-
738UbiquitinationLEKEVLDKNDMVELL
HHHHHCCCCCCHHHH
51.16-
763PhosphorylationYEEFVEGTGSLDEDT
HHHHHCCCCCCCCCC
15.3026471730
765PhosphorylationEFVEGTGSLDEDTSL
HHHCCCCCCCCCCCC
32.2728857561
770PhosphorylationTGSLDEDTSLPEGLK
CCCCCCCCCCCCHHH
30.0728857561
771PhosphorylationGSLDEDTSLPEGLKD
CCCCCCCCCCCHHHH
55.0028348404

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of AFG32_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of AFG32_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of AFG32_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
A4_HUMANAPPphysical
21832049
AT1A1_HUMANATP1A1physical
26344197
ATPA_HUMANATP5A1physical
26344197
PHB_HUMANPHBphysical
26344197
PHB2_HUMANPHB2physical
26344197
RPN1_HUMANRPN1physical
26344197
TMCO1_HUMANTMCO1physical
26344197
QCR8_HUMANUQCRQphysical
26344197

Drug and Disease Associations
Kegg Disease
H00063 Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
H00473 Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (
OMIM Disease
610246Spinocerebellar ataxia 28 (SCA28)
614487Spastic ataxia 5, autosomal recessive (SPAX5)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB00171Adenosine triphosphate
Regulatory Network of AFG32_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-306 AND LYS-543, AND MASSSPECTROMETRY.

TOP